Eli Lilly cuts price of weight-loss drug Zepbound
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly stock surges past $840, outperforming the S&P 500. Click here to learn why LLY stock is still undervalued and why ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results